Pfizer said Tuesday it expects to apply for emergency use authorization to administer its COVID-19 vaccine to children ages 2 to 11 in September.
The company made the comments in an earnings call on Tuesday and also said it plans to file for full approval from the Food and Drug Administration for the use of its vaccine in 16- to 85-year-olds, beyond the emergency use authorization granted in December. The approval would be a milestone that could help alleviate some Americans’ concerns and vaccine hesitancy.
- Insane Vid — Man Stream Admission he Killed His Ex-Girlfriend as he prepares to Kill Ex-Wife
- Aussie Police confirm use of controversial LRAD Weapon against Canberra protestors
- Not so fast. The Very Misleading Article By a Priest on Drugs And Abortion Testing
- Prince Andrew agrees to settlement in Jeffrey Epstein sex abuse case
- JAMA: Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US
- Is Gavin Newsom hiding because he got Bell’s Palsy from Booster Shot?
- Liars Game — CDC withheld massive amounts of COVID data to ‘prevent vaccine hesitancy’
- UK becomes first country to approve Merck’s “game changer” COVID-19 pill.
- Doomsday Approaches: Biden Announces Commission to Study Overhauling Supreme Court
- Google Docs now autocorrecting to gender neutral and politically correct language